Erichsen Martina M, Løvås Kristian, Fougner Kristian J, Svartberg Johan, Hauge Erik R, Bollerslev Jens, Berg Jens P, Mella Bjarne, Husebye Eystein S
Section for Endocrinology, Department of Medicine, Haukeland University Hospital, N-5021 Bergen, Norway.
Eur J Endocrinol. 2009 Feb;160(2):233-7. doi: 10.1530/EJE-08-0550. Epub 2008 Nov 14.
Primary adrenal insufficiency (Addison's disease) is a rare autoimmune disease. Until recently, life expectancy in Addison's disease patients was considered normal.
To determine the mortality rate in Addison's disease patients.
i) Patients registered with Addison's disease in Norway during 1943-2005 were identified through search in hospital diagnosis registries. Scrutiny of the medical records provided diagnostic accuracy and age at diagnosis. ii) The patients who had died were identified from the National Directory of Residents. iii) Background mortality data were obtained from Statistics Norway, and standard mortality rate (SMR) calculated. iv) Death diagnoses were obtained from the Norwegian Death Cause Registry.
Totally 811 patients with Addison's disease were identified, of whom 147 were deceased. Overall SMR was 1.15 (95% confidence intervals (CI) 0.96-1.35), similar in females (1.18 (0.92-1.44)) and males (1.10 (0.80-1.39)). Patients diagnosed before the age of 40 had significantly elevated SMR at 1.50 (95% CI 1.09-2.01), most pronounced in males (2.03 (1.19-2.86)). Acute adrenal failure was a major cause of death; infection and sudden death were more common than in the general population. The mean ages at death for females (75.7 years) and males (64.8 years) were 3.2 and 11.2 years less than the estimated life expectancy.
Addison's disease is still a potentially lethal condition, with excess mortality in acute adrenal failure, infection, and sudden death in patients diagnosed at young age. Otherwise, the prognosis is excellent for patients with Addison's disease.
原发性肾上腺皮质功能减退症(艾迪生病)是一种罕见的自身免疫性疾病。直到最近,艾迪生病患者的预期寿命仍被认为是正常的。
确定艾迪生病患者的死亡率。
i)通过查阅医院诊断登记册,确定1943年至2005年期间在挪威登记患有艾迪生病的患者。仔细审查病历以确定诊断准确性和诊断时的年龄。ii)从全国居民名录中确定已死亡的患者。iii)从挪威统计局获取背景死亡率数据,并计算标准化死亡率(SMR)。iv)从挪威死亡原因登记处获取死亡诊断信息。
共识别出811例艾迪生病患者,其中147例已死亡。总体SMR为1.15(95%置信区间(CI)0.96 - 1.35),女性(1.18(0.92 - 1.44))和男性(1.1(0.80 - 1.39))相似。40岁之前诊断出的患者SMR显著升高,为1.50(95%CI 1.09 - 2.01),在男性中最为明显(2.03(1.19 - 2.86))。急性肾上腺衰竭是主要死因;感染和猝死比普通人群更常见。女性(75.7岁)和男性(64.8岁)的平均死亡年龄分别比预期寿命少3.2岁和11.2岁。
艾迪生病仍然是一种潜在的致命疾病,急性肾上腺衰竭、感染以及年轻患者的猝死导致死亡率过高。否则,艾迪生病患者的预后良好。